VeriChip Wants To Test Human-Implantable RFID On Military
The amount of information on the chip would be up to the military sponsors and could range from basic name and serial number to more advanced medical data.
VeriChip is pitching its human implantable RFID chips to the U.S. military.
VeriChip spokesperson Nicole Philbin confirmed Wednesday that the company's Board Chairman Scott Silverman has held informal meetings with U.S. Navy and Air Force leaders to suggest a feasibility study of its VeriMed system.
The system relies on an implant the size of a grain of rice, which VeriChip claims has an encrypted 16-digit identification number. Philbin said only proprietary RFID readers can decipher the number, which is then entered into a secure database. A login name and password are required to access the database on a secure Web site, Philbin said, adding that the system is more secure and more effective than things people normally carry in their wallets.
Like overall participation, the amount of information attached to the identification number is at the discretion of individuals who volunteer for the program, Philbin said. That could be limited to the most basic information, like name and telephone number, or it could contain advance directives, organ donor status and more.
VeriChip is owned by Applied Digital, which lists federal agencies among its clients. The company markets the VeriMed system as a way to ensure that emergency responders and healthcare providers can identify a patient who is or unable to communicate and learn of allergies and medical conditions.
"The Department of Defense already has an electronic health records program, and VeriChip would like to enhance the quality of care for vets and military members," Philbin said. "There is no power source. It can't be tracked. It's not a GPS device. It contains no information other than the identification number. It's not mandatory. If a person with the device is presented to an emergency room unconscious, they may be allergic to something or have a preexisting condition, and that information is crucial."
The RFID implants were approved as Class II medical devices by the U.S. Food and Drug Administration in October 2004. In a letter, Donna-Bea Tillman, PhD, director of the F.D.A.'s Office of Device Evaluation, Center for Devices and Radiological Health, outlined potential health risks associated with VeriChip implants. They include adverse tissue reaction; migration of implanted transponder; compromised information security; failure of implanted transponder, inserter or electronic scanner; electromagnetic interference; electrical hazards; magnetic resonance imaging incompatibility; and needle stick.
"With any F.D.A. approval, they state the potential risks," Philbin said. "The F.D.A. is satisfied with the product and that's why they have given it the O.K."
Some people have implanted chips in themselves to experiment with the technology and for fast access to their computer accounts.
Critics contend that VeriChip is peddling its products to governments, while targeting vulnerable populations " like the elderly, inmates, immigrants and members of the military, who have less choice than the general population. They claim that RFID proponents' eventual goal is to "chip" as many people as possible, then track consumers and their behaviors for marketing purposes.
The Business of Going DigitalDigital business isn't about changing code; it's about changing what legacy sales, distribution, customer service, and product groups do in the new digital age. It's about bringing big data analytics, mobile, social, marketing automation, cloud computing, and the app economy together to launch new products and services. We're seeing new titles in this digital revolution, new responsibilities, new business models, and major shifts in technology spending.
Join InformationWeek’s Lorna Garey and Mike Healey, president of Yeoman Technology Group, an engineering and research firm focused on maximizing technology investments, to discuss the right way to go digital.